Cefamezin



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 50.7%
Infection Prophylaxis 7.9%
Pain 5.7%
Induction Of Anaesthesia 4.3%
Cellulitis 2.9%
Fungal Peritonitis 2.9%
Pneumonia 2.9%
Postoperative Care 2.9%
Upper Respiratory Tract Infection 2.9%
Anaesthesia 2.1%
Appendicitis 2.1%
Infection 2.1%
Peritonitis 2.1%
Prophylaxis 2.1%
Skin Laceration 2.1%
Gastric Operation 1.4%
Acute Respiratory Distress Syndrome 0.7%
Beta Haemolytic Streptococcal Infection 0.7%
Endocarditis 0.7%
Granulocytopenia 0.7%
Urticaria 14.8%
Vomiting 13.1%
Shock 9.8%
Hot Flush 6.6%
Pyrexia 6.6%
Respiratory Arrest 6.6%
Hepatic Function Abnormal 4.9%
Rash Papular 4.9%
Syncope Vasovagal 4.9%
Convulsion 3.3%
Tonic Convulsion 3.3%
Urinary Incontinence 3.3%
Vitamin K Deficiency 3.3%
Wheezing 3.3%
White Blood Cell Count Increased 3.3%
Blood Pressure Decreased 1.6%
Disseminated Intravascular Coagulation 1.6%
Erythema 1.6%
Flushing 1.6%
Hypotonia 1.6%
Secondary
Drug Use For Unknown Indication 21.6%
Hypertension 9.4%
Pneumonia 7.5%
Product Used For Unknown Indication 7.5%
Anaesthesia 7.2%
Nasopharyngitis 4.7%
Pyrexia 4.7%
Diabetes Mellitus 4.1%
Postoperative Analgesia 4.1%
Antibiotic Prophylaxis 3.8%
Infection Prophylaxis 3.4%
Diarrhoea 2.8%
Infection 2.8%
Prophylaxis Against Gastrointestinal Ulcer 2.8%
Thrombosis Prophylaxis 2.8%
Psoas Abscess 2.5%
Back Pain 2.2%
Prophylaxis 2.2%
Abscess 1.9%
Anaesthetic Premedication 1.9%
Tubulointerstitial Nephritis 8.2%
Lung Disorder 6.6%
Rash 6.6%
Renal Failure Acute 6.6%
Stevens-johnson Syndrome 6.6%
Vomiting 6.6%
Acute Generalised Exanthematous Pustulosis 4.9%
Acute Respiratory Distress Syndrome 4.9%
Blood Bilirubin Increased 4.9%
Laryngeal Oedema 4.9%
Pyrexia 4.9%
Renal Impairment 4.9%
Respiratory Arrest 4.9%
Sepsis 4.9%
Anaphylactic Shock 3.3%
Drug Rash With Eosinophilia And Systemic Symptoms 3.3%
Hepatic Function Abnormal 3.3%
Hyperthermia 3.3%
Interstitial Lung Disease 3.3%
Nephritis Interstitial 3.3%
Concomitant
Drug Use For Unknown Indication 26.2%
Prophylaxis 13.9%
Hypertension 9.2%
Infection Prophylaxis 5.9%
Thrombosis Prophylaxis 4.6%
Bursitis Infective 4.5%
Colitis Ulcerative 4.5%
Insomnia 4.4%
Rheumatoid Arthritis 4.1%
Cardiac Failure 3.0%
Foetal Exposure During Pregnancy 2.8%
Acute Myocardial Infarction 2.4%
Pneumonia 2.0%
Pulmonary Hypertension 2.0%
Gastritis 1.9%
Osteoporosis 1.8%
Parkinson's Disease 1.7%
Prophylaxis Against Gastrointestinal Ulcer 1.7%
Epilepsy 1.6%
Pain 1.6%
White Blood Cell Count Decreased 11.1%
White Blood Cell Count Increased 8.7%
Malaise 7.1%
Femur Fracture 6.3%
Hepatic Function Abnormal 5.6%
Vomiting 5.6%
Myasthenia Gravis 4.8%
Paralysis 4.8%
Post Procedural Haemorrhage 4.8%
Verbal Abuse 4.8%
Deep Vein Thrombosis 4.0%
Hypoxia 4.0%
Platelet Count Decreased 4.0%
Pulmonary Haemorrhage 4.0%
Sepsis 4.0%
Toxic Epidermal Necrolysis 4.0%
Febrile Neutropenia 3.2%
Loss Of Consciousness 3.2%
Pyrexia 3.2%
Therapeutic Response Decreased 3.2%